Invasive Candidiasis: Update and Current Challenges in the Management of This Mycosis in South America
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Abstract
Invasive candidiasis encompassing Candida bloodstream infections and deep-seated candidiasis can become a persistent health problem. These infections are caused by Candida species and have high morbidity and mortality rates. Species distribution, access to diagnosis, treatment and mortality are different around the world. The mortality rate is high in South America (30–70%), and Candida albicans is the most prevalent species in this region. However, a global epidemiological shift to non-albicans species has been observed. In this group, C. parapsilosis is the species most frequently detected, followed by C. tropicalis, and at a slower rate, C. glabrata, which has also increased, in addition to the emerging C. auris, resistance to several drugs. This article summarizes relevant aspects of candidemia pathogenesis, such as the mechanisms of fungal invasion, immune response, and the impact of genetic defects that increase host susceptibility to developing the infection. We also discuss relevant aspects of treatment and future challenges in South America.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Epidemiology of candidemia in South America (2017–2022). Data about C. auris were recently published by the Pan American Health Organization (PAHO) [28]. Species distribution might have changed since these data were collected.](https://figures.cochat.ai/paper-figures/3fd464907e0241f4a81809f061bfe290/invasive-candidiasis-update-and-current-challenges-in-the-management-of-this-figure-1.jpg)

![Figure 3 Invasive Candidiasis: Organs Susceptible of Infection by Candida spp. and Resulting Diseases. The names of diseases agree with those described by Pappas et al. [12].](https://figures.cochat.ai/paper-figures/a6bc7ef4e3a04307a25e0e5fe6a7e743/invasive-candidiasis-update-and-current-challenges-in-the-management-of-this-figure-3.jpg)
![Figure 4 Algorithm for management of Candida sepsis adapted from Keighley et al. and Thompson et al. [94,95].](https://figures.cochat.ai/paper-figures/9306af45413d483cb2762634c3142b37/invasive-candidiasis-update-and-current-challenges-in-the-management-of-this-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In South America, candidemia incidence ranges from 0.6–6.0 per 1000 hospital admission.48”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In South America, studies found that the mortality rate varies from 30–70%.48”
From Epidemiology of Invasive Candidiasis (2024) · cites this paper as [48]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 3×
“Although current guidelines recommend therapy with FLZ AFST, not all patients are tested due to a lack of supplies in regional laboratories [86].”
BackgroundMethodPappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
Romani, L. (2011) · Nature Reviews Immunology · doi:10.1038/nri2939 · Cited by 1,793 · cited 3×
“Circulating cells such as neutrophils and resident macrophages act as effector cells in the control of fungal load through the production of metabolites such as H2O2, superoxide anion, nitric oxide (NO) and peroxide nitrites, which have a more powerful candidacidal activity compared to their progenitors [47,54].”
BackgroundLockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636 · cited 4×
“quickly to different parts of the world [12,26].”
BackgroundInfluentialGarcia-Vidal, C., Sanjuan, G., Moreno-García, E., Puerta-Alcalde, P., Garcia-Pouton, N., Chumbita, M., Fernandez-Pittol, M., Pitart, C., Inciarte, A., Bodro, M., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.07.041 · Cited by 1,022 · cited 1×
“7% (7/989) [35], Italy: 8% (3/43) [36], and the UK: 12.”
Pappas, P. G., Rex, J. H., Lee, J., Hamill, R. J., Larsen, R. A., Powderly, W., Kauffman, C. A., Hyslop, N., Mangino, J. E., Chapman, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376906 · Cited by 845 · cited 1×
“Early identification of candidemia and treatment with appropriate antifungal drugs certainly reduce morbidity and mortality [81,82].”
BackgroundA Homozygous CARD9 Mutation in a Family with Susceptibility to Fungal Infections
Glocker, E.-O., Hennigs, A., Nabavi, M., Schäffer, A. A., Woellner, C., Salzer, U., Pfeifer, D., Veelken, H., Warnatz, K., Tahami, F., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810719 · Cited by 800 · cited 1×
“in 2009 [71] in a large Iranian consanguineous family consisting of 43 members.”
BackgroundHost-Pathogen Interactions: Redefining the Basic Concepts of Virulence and Pathogenicity
Casadevall, A., & Pirofski, L.-A. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.3703-3713.1999 · Cited by 769 · cited 3×
“The biofilms grow attached to medical devices or host tissues [18] and in addition to their difficult eradication, the final phase involves dispersion of non-adherent cells, which results in the initiation of newer biofilms and further dissemination to other tissues [52,53].”
BackgroundHuman dectin-1 deficiency and mucocutaneous fungal infections
Ferwerda, B., Ferwerda, G., Plantinga, T. S., Willment, J. A., van Spriel, A. B., Venselaar, H., Elbers, C. C., Johnson, M. D., Cambi, A., Huysamen, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901053 · Cited by 752 · cited 5×
“CLRs constitute a heterogeneous superfamily of transmembrane and soluble receptors, which contain conserved lectin-like domains that recognize carbohydrate polymers (mannans, glucans and chitin) found in the fungal-cell wall [67,68].”
BackgroundInfluentialPfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
Clancy, C. J., & Nguyen, M. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit006 · Cited by 688
Immune defence against Candida fungal infections
Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Kullberg, B.-J., & van de Veerdonk, F. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3897 · Cited by 642 · cited 3×
“They are particularly involved in the onset of infection during the first 24–48 h, where an effective immune response is crucial to prevent disease progression [30,68,78].”
BackgroundHughes, S., Troise, O., Donaldson, H., Mughal, N., & Moore, L. S. P. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.06.025 · Cited by 642 · cited 2×
“albicans the most frequently species isolates [39,42,43].”
BackgroundDectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans
Saijo, S., Fujikado, N., Furuta, T., Chung, S.-H., Kotaki, H., Seki, K., Sudo, K., Akira, S., Adachi, Y., Ohno, N., et al. (2007) · Nature Immunology · doi:10.1038/ni1425 · Cited by 611
White, P. L., Dhillon, R., Cordey, A., Hughes, H., Faggian, F., Soni, S., Pandey, M., Whitaker, H., May, A., Morgan, M., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1298 · Cited by 445
Morgan, J., Meltzer, M. I., Plikaytis, B. D., Sofair, A. N., Huie-White, S., Wilcox, S., Harrison, L. H., Seaberg, E. C., Hajjeh, R. A., & Teutsch, S. M. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502581 · Cited by 437
Population-Based Analysis of Invasive Fungal Infections, France, 2001–2010
Bitar, D., Lortholary, O., Le Strat, Y., Nicolau, J., Coignard, B., Tattevin, P., Che, D., & Dromer, F. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2007.140087 · Cited by 426 · cited 14×
“Compared with FLZ AFST, echinocandin AFST is used less frequently, which is predictable because echinocandin AFST is not recommended for all bloodstream isolates [89].”
BackgroundInfluentialEpidemiology of invasive candidiasis
Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376 · cited 1×
“Table 1 summarizes the antifungal drugs used for the clinical management of invasive candidiasis, categorized as primary and alternative, including recently introduced new drugs [98,99].”
BackgroundEpidemiology of candidemia in Latin America: a laboratory-based survey
Nucci, M., Queiroz-Telles, F., Alvarado-Matute, T., Tiraboschi, I. N., Cortes, J., Zurita, J., Guzman-Blanco, M., Santolaya, M. E., Thompson, L., Sifuentes-Osornio, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059373 · Cited by 374 · cited 4×
“The MIC distribution of azoles in this study might be higher than in the Clinical and Laboratory Standards Institute CLSI M50 [4].”
BackgroundResultInfluentialCandida albicans Als3, a multifunctional adhesin and invasin
Liu, Y., & Filler, S. G. (2011) · Eukaryotic Cell · doi:10.1128/ec.00279-10 · Cited by 354
d'Enfert, C., Kaune, A.-K., Alaban, L.-R., Chakraborty, S., Cole, N., Delavy, M., Kosmala, D., Marsaux, B., Fróis-Martins, R., Morelli, M., et al. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa060 · Cited by 347 · cited 1×
“Its growth is strictly controlled by the host immune system and the regulatory mechanisms provided by the normal microbiota [31].”
BackgroundFalagas, M. E., Roussos, N., & Vardakas, K. Z. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.04.006 · Cited by 346 · cited 1×
“Because of the increasing frequency of infections caused by non-albicans Candida [83], increasing levels of FLZ resistance [84], and evidence that echinocandins are more effective than FLZ [85], the current international guidelines strongly recommend echinocandins instead of FLZ as initial treatment for candidemia in…”
BackgroundChowdhary, A., Tarai, B., Singh, A., & Sharma, A. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2611.203504 · Cited by 330 · cited 1×
“5% (15/596) [38], Iran 5% (53/ 1059) [39], and China reported”
Bassetti, M., Azoulay, E., Kullberg, B.-J., Ruhnke, M., Shoham, S., Vazquez, J., Giacobbe, D. R., & Calandra, T. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1751 · Cited by 327
The French Mycosis Study Group, Lortholary, O., Renaudat, C., Sitbon, K., Madec, Y., Denoeud-Ndam, L., Wolff, M., Fontanet, A., Bretagne, S., & Dromer, F. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3408-3 · Cited by 312 · cited 2×
“Compared with FLZ AFST, echinocandin AFST is used less frequently, which is predictable because echinocandin AFST is not recommended for all bloodstream isolates [89].”
BackgroundOrgan-Specific Innate Immune Responses in a Mouse Model of Invasive Candidiasis
Lionakis, M. S., Lim, J. K., Lee, C.-C. R., & Murphy, P. M. (2011) · Journal of Innate Immunity · doi:10.1159/000321157 · Cited by 302 · cited 1×
“Their absence or failure of activation/recruitment mechanisms lead to increased susceptibility to invasive fungal infections, reduced control of fungal growth and accelerated mortality, both in human and animal models [75,76].”
BackgroundCandida albicans interactions with epithelial cells and mucosal immunity
Naglik, J. R., Moyes, D. L., Wächtler, B., & Hube, B. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.06.009 · Cited by 277
Arastehfar, A., Carvalho, A., Nguyen, M. H., Hedayati, M. T., Netea, M. G., Perlin, D. S., & Hoenigl, M. (2020) · Journal of Fungi · doi:10.3390/jof6040211 · Cited by 272
Lewis, R. E., Cahyame‐Zuniga, L., Leventakos, K., Chamilos, G., Ben‐Ami, R., Tamboli, P., Tarrand, J., Bodey, G. P., Luna, M., & Kontoyiannis, D. P. (2013) · Mycoses · doi:10.1111/myc.12081 · Cited by 248 · cited 2×
“[59] analyzed autopsies of cancer patients collected over 20 years and reported an increase in the incidence of systemic candidiasis as well as the presence of C.”
BackgroundBassetti, M., Taramasso, L., Nicco, E., Molinari, M. P., Mussap, M., & Viscoli, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024198 · Cited by 216 · cited 1×
“the initial antifungal therapy is usually selected based on local epidemiology, antifungal resistance patterns, and individual patient factors [90].”
BackgroundSmeekens, S. P., Ng, A., Kumar, V., Johnson, M. D., Plantinga, T. S., van Diemen, C., Arts, P., Verwiel, E. T. P., Gresnigt, M. S., Fransen, K., et al. (2013) · Nature Communications · doi:10.1038/ncomms2343 · Cited by 213 · cited 1×
“[49] studied the downstream signaling of type I interferon and reported that STAT1 polymorphisms are associated with candidemia.”
BackgroundHost Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts
Lionakis, M. S., & Levitz, S. M. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053318 · Cited by 209 · cited 1×
“Circulating cells such as neutrophils and resident macrophages act as effector cells in the control of fungal load through the production of metabolites such as H2O2, superoxide anion, nitric oxide (NO) and peroxide nitrites, which have a more powerful candidacidal activity compared to their progenitors [47,54].”
BackgroundCandida albicans-Induced Epithelial Damage Mediates Translocation through Intestinal Barriers
Allert, S., Förster, T. M., Svensson, C.-M., Richardson, J. P., Pawlik, T., Hebecker, B., Rudolphi, S., Juraschitz, M., Schaller, M., Blagojevic, M., et al. (2018) · mBio · doi:10.1128/mbio.00915-18 · Cited by 208 · cited 2×
“Four leading conditions predispose an invasive human infection (Figure 2) [1,12,29].”
BackgroundRisk Factors for Invasive Candida Infection in Critically Ill Patients
Thomas-Rüddel, D. O., Schlattmann, P., Pletz, M., Kurzai, O., & Bloos, F. (2022) · CHEST · doi:10.1016/j.chest.2021.08.081 · Cited by 203 · cited 1×
“A recent systemic review and meta-analysis showed that broad-spectrum antimicrobials, blood transfusions, Candida colonization, CVCs and total parenteral nutrition were associated with the maximum risk of invasive candidiasis [34].”
BackgroundIncreased incidence of candidemia in a tertiary care hospital with the COVID‐19 pandemic
Nucci, M., Barreiros, G., Guimarães, L. F., Deriquehem, V. A. S., Castiñeiras, A. C., & Nouér, S. A. (2021) · Mycoses · doi:10.1111/myc.13225 · Cited by 193 · cited 2×
“4% of episodes, at a median of two days after candidemia diagnosis [4,44].”
BackgroundTocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
Antinori, S., Bonazzetti, C., Gubertini, G., Capetti, A., Pagani, C., Morena, V., Rimoldi, S., Galimberti, L., Sarzi-Puttini, P., & Ridolfo, A. L. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102564 · Cited by 183
Candida and Host Determinants of Susceptibility to Invasive Candidiasis
Lionakis, M. S., & Netea, M. G. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003079 · Cited by 176 · cited 1×
“They are particularly involved in the onset of infection during the first 24–48 h, where an effective immune response is crucial to prevent disease progression [30,68,78].”
BackgroundNosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis
Pfaller, M. A., & Castanheira, M. (2015) · Medical Mycology · doi:10.1093/mmy/myv076 · Cited by 161
Salehi, M., Ahmadikia, K., Mahmoudi, S., Kalantari, S., Jamalimoghadamsiahkali, S., Izadi, A., Kord, M., Dehghan Manshadi, S. A., Seifi, A., Ghiasvand, F., et al. (2020) · Mycoses · doi:10.1111/myc.13137 · Cited by 161
Colombo, A. L., Guimarães, T., Camargo, L. F. A., Richtmann, R., de Queiroz-Telles, F., Salles, M. J. C., da Cunha, C. A., Yasuda, M. A. S., Moretti, M. L., & Nucci, M. (2013) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2013.02.001 · Cited by 153
(2013) · PubMed · Cited by 150
Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia
Plantinga, T. S., Johnson, M. D., Scott, W. K., van de Vosse, E., Velez Edwards, D. R., Smith, P. B., Alexander, B. D., Yang, J. C., Kremer, D., Laird, G. M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir867 · Cited by 141 · cited 2×
“[48] studied the incidence of disseminated candidiasis in bone marrow transplant recipients with this polymorphism and reported that this mutation predisposes them to the development of mucocutaneous candidiasis but not invasive infection.”
BackgroundRisk Factors and Predictors of Outcome in Patients with Cancer and Breakthrough Candidemia
Uzun, O., Ascioglu, S., Anaissie, E. J., & Rex, J. H. (2001) · Clinical Infectious Diseases · doi:10.1086/320757 · Cited by 138 · cited 1×
“They are particularly involved in the onset of infection during the first 24–48 h, where an effective immune response is crucial to prevent disease progression [30,68,78].”
BackgroundThe role of neutrophils in host defense against invasive fungal infections
Desai, J. V., & Lionakis, M. S. (2018) · Current Clinical Microbiology Reports · doi:10.1007/s40588-018-0098-6 · Cited by 131 · cited 2×
“Their absence or failure of activation/recruitment mechanisms lead to increased susceptibility to invasive fungal infections, reduced control of fungal growth and accelerated mortality, both in human and animal models [75,76].”
BackgroundMechanisms of fungal dissemination
Strickland, A. B., & Shi, M. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03736-z · Cited by 127
Thomaz, D. Y., de Almeida, J. N., Lima, G. M. E., Nunes, M. D. O., Camargo, C. H., Grenfell, R. D. C., Benard, G., & Del Negro, G. M. B. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02997 · Cited by 124
Wagener, J., MacCallum, D. M., Brown, G. D., & Gow, N. A. R. (2017) · mBio · doi:10.1128/mbio.01820-16 · Cited by 122 · cited 1×
“[80] reported that chitin exposure during C.”
Candidemia: Evolution of Drug Resistance and Novel Therapeutic Approaches
Tortorano, A. M., Prigitano, A., Morroni, G., Brescini, L., & Barchiesi, F. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s274872 · Cited by 122 · cited 1×
“Ostesaconazole is a novel tetrazole that inhibits lanosterol demethylase and Fosmanogepix is a new type of antifungal agent that inhibits Gtw1, an enzyme that traffics and anchors mannoproteins [103].”
BackgroundNeutrophil extracellular traps in fungal infection
Urban, C. F., & Nett, J. E. (2019) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2018.03.020 · Cited by 120 · cited 1×
“These cells are rapidly recruited to the site of infection, contributing to fungal control by phagocytosis, respiratory burst, degranulation, release of pro- and anti-inflammatory cytokines, and release of extracellular traps (NETs) [68,75,77].”
Backgroundda Matta, D. A., Souza, A. C. R., & Colombo, A. L. (2017) · Journal of Fungi · doi:10.3390/jof3020024 · Cited by 120
Mastrangelo, A., Germinario, B. N., Ferrante, M., Frangi, C., Li Voti, R., Muccini, C., Ripa, M., COVID-BioB Study Group, Canetti, D., Castiglioni, B., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1594 · Cited by 112 · cited 1×
“albicans the most frequently species isolates [39,42,43].”
Name Changes for Fungi of Medical Importance, 2018 to 2019
Borman, A. M., & Johnson, E. M. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.01811-20 · Cited by 111 · cited 1×
“It is important to keep in mind that, in agreement with recent updates in the clinical microbiology nomenclature [7], Candida krusei and C.”
ResultParker, J. C., McCloskey, J. J., & Knauer, K. A. (1976) · American Journal of Clinical Pathology · doi:10.1093/ajcp/65.6.991 · Cited by 108
Prevalence of biofilms in Candida spp. bloodstream infections: A meta-analysis
Atiencia-Carrera, M. B., Cabezas-Mera, F. S., Tejera, E., & Machado, A. (2022) · PLOS ONE · doi:10.1371/journal.pone.0263522 · Cited by 107 · cited 1×
“[66] reported one extensive meta-analysis of 214 studies about the rates, types and antifungal resistance of Candida biofilms among hospitalized patients between 1995 and 2020.”
BackgroundCandida albicans Interactions with Mucosal Surfaces during Health and Disease
Nikou, S.-A., Kichik, N., Brown, R., Ponde, N., Ho, J., Naglik, J., & Richardson, J. (2019) · Pathogens · doi:10.3390/pathogens8020053 · Cited by 103 · cited 2×
“Following adherence, epithelial invasion can occur through induced endocytosis, which involves fungal invasins, such as Als3 and Ssa1 [61,63], or active penetratio .”
BackgroundThomaz, D. Y., de Almeida, J. N., Sejas, O. N. E., Del Negro, G. M. B., Carvalho, G. O. M. H., Gimenes, V. M. F., de Souza, M. E. B., Arastehfar, A., Camargo, C. H., Motta, A. L., et al. (2021) · Journal of Fungi · doi:10.3390/jof7040259 · Cited by 95
Canela, H. M. S., Cardoso, B., Vitali, L. H., Coêlho, H. C., Martínez, R., & Ferreira, M. E. D. S. (2017) · Mycoses · doi:10.1111/myc.12695 · Cited by 94
Candida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast
Kean, R., Brown, J., Gulmez, D., Ware, A., & Ramage, G. (2020) · Journal of Fungi · doi:10.3390/jof6010030 · Cited by 86
The Candida albicans-Specific Gene EED1 Encodes a Key Regulator of Hyphal Extension
Martin, R., Moran, G. P., Jacobsen, I. D., Heyken, A., Domey, J., Sullivan, D. J., Kurzai, O., & Hube, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018394 · Cited by 85 · cited 1×
“Intracellular hyph l exten ion depends on EED1 (Epithelial Escape and Dissemin tion 1) xpression [64] a d con inu d fungal elongatio results in th iercing of epithelial cells and subsequent spreading.”
Backgroundde Medeiros, M. A. P., de Melo, A. P. V., Bento, A. D. O., de Souza, L. B. F. C., Neto, F. D. A. B., Garcia, J. B.-L., Zuza-Alves, D. L., Francisco, E. C., Melo, A. S. D. A., & Chaves, G. M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221033 · Cited by 83
Fungal invasion of epithelial cells
Yang, W., Yan, L., Wu, C., Zhao, X., & Tang, J. (2014) · Microbiological Research · doi:10.1016/j.micres.2014.02.013 · Cited by 79 · cited 2×
“Following adherence, epithelial invasion can occur through induced endocytosis, which involves fungal invasins, such as Als3 and Ssa1 [61,63], or active penetratio .”
BackgroundCandida infection of the central nervous system following neurosurgery: a 12-year review
O’Brien, D. J., Stevens, N. T., Lim, C. H., O’Brien, D. F., Smyth, E. G., Fitzpatrick, F., & Humphreys, H. (2011) · Acta Neurochirurgica · doi:10.1007/s00701-011-0990-9 · Cited by 76 · cited 3×
“gitis, micro and macro abscesses, and vascular complications [96,97].”
BackgroundKeighley, C., Cooley, L., Morris, A. J., Ritchie, D., Clark, J. E., Boan, P., & Worth, L. J. (2021) · Internal Medicine Journal · doi:10.1111/imj.15589 · Cited by 73
Ziccardi, M., Souza, L. O. P., Gandra, R. M., Galdino, A. C. M., Rossit, A. R. B., Nunes, A. P. F., Ribeiro, M. A., Branquinha, M. H., & dos Santos, A. L. S. (2015) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2015.08.003 · Cited by 68
Monocytes and the Host Response to Fungal Pathogens
Heung, L. J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00034 · Cited by 66 · cited 1×
“In recent years, the role of monocytes (Mo) and tissue-resident macrophages (MΦ) has been explored [79].”
BackgroundAllert, S., Schulz, D., Kämmer, P., Großmann, P., Wolf, T., Schäuble, S., Panagiotou, G., Brunke, S., & Hube, B. (2022) · Virulence · doi:10.1080/21505594.2022.2026037 · Cited by 66 · cited 2×
“li iting therapeutic options and associated ith high ortality rates (30–60 ) [27].”
BackgroundCortés, J. A., Ruiz, J. F., Moreno, L. N. M., & Lemos, E. V. (2020) · Biomédica · doi:10.7705/biomedica.4400 · Cited by 61 · cited 2×
“0 per 1000 hospital admissions, and despite all advances in the development of new diagnostic and therapeutic tools for fungal infections, failures in infection control plus the struggle to apply appropriate treatment due to costs and delays determine that the current mortality rate achieves 30–78% [5,6].”
BackgroundWalsh, T. J., Katragkou, A., Chen, T. K., Salvatore, C. M., & Roilides, E. (2019) · Journal of Fungi · doi:10.3390/jof5010011 · Cited by 59 · cited 2×
“gitis, micro and macro abscesses, and vascular complications [96,97].”
BackgroundKobayashi, T., Marra, A. R., Schweizer, M. L., Eyck, P. T., Wu, C., Alzunitan, M. A., Salinas, J. L., Siegel, M., Farmakiotis, D., Auwaerter, P. G., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa270 · Cited by 59 · cited 1×
“It is recommended that all patients with candidemia be assisted by infectious disease specialists for outcome improvement [91].”
BackgroundClark, C., & Drummond, R. (2019) · Pathogens · doi:10.3390/pathogens8020045 · Cited by 58 · cited 1×
“Other drugs that downregulate the function of immune cells involved in fungal control, such as corticosteroids, chemotherapeutic agents and immunosuppressive drugs, increase the risk of fungal infections as well [33].”
BackgroundSmeekens, S. P., Gresnigt, M. S., Becker, K. L., Cheng, S.-C., Netea, S. A., Jacobs, L., Jansen, T., van de Veerdonk, F. L., Williams, D. L., Joosten, L. A. B., et al. (2015) · Cytokine · doi:10.1016/j.cyto.2014.10.013 · Cited by 55 · cited 1×
“The Q295X mutation was associated with the occurrence of multiple cases of chronic mucocutaneous candidiasis and increased susceptibility to disseminated and cerebral forms of mycosis [72].”
BackgroundWhibley, N., Jaycox, J. R., Reid, D. M., Garg, A. V., Taylor, J. A., Clancy, C. J., Nguyen, M. H., Biswas, P. S., McGeachy, M. J., Brown, G. D., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500870 · Cited by 54
Genetic Susceptibility to Fungal Infections and Links to Human Ancestry
Naik, B., Ahmed, S. M. Q., Laha, S., & Das, S. P. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.709315 · Cited by 52 · cited 2×
“defects in specific adaptive immunity and human ancestry have been identified [50,51].”
BackgroundNoninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
Thompson, G. R., Boulware, D. R., Bahr, N. C., Clancy, C. J., Harrison, T. S., Kauffman, C. A., Le, T. P., Miceli, M. H., Mylonakis, E. E., Nguyen, M. H., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac112 · Cited by 52 · cited 2×
“Most experts recommend empirical treatment for suspected cases and patients hospitalized in ICUs for more than 7 days with fever and hemodynamic instability and high scores in the clinical prediction rules [94].”
BackgroundA prospective, multi-center study of Candida bloodstream infections in Chile
Santolaya, M. E., Thompson, L., Dona Benadof, F., Tapia, C. V., Legarraga, P., Cortés, C. P., Rabello, M., Valenzuela, R., Rojas, P., Ricardo Rabagliati, B., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212924 · Cited by 50 · cited 1×
“[15] provided data from 384 cases of candidemia in patients from 18 different hospitals.”
Bustamante, B., Martins, M. A., Bonfietti, L. X., Szeszs, M. W., Jacobs, J. A., García, C., & Melhem, M. D. S. C. (2014) · Journal of Medical Microbiology · doi:10.1099/jmm.0.071167-0 · Cited by 48 · cited 2×
“parapsilosis sensu lato in the absence of other cryptic species [24].”
BackgroundEpidemiology of Candida isolates from Intensive Care Units in Colombia from 2010 to 2013
Motoa, G., Muñoz, J. S., Oñate, J., Pallares, C., Hernández, C., & Villegas, M. V. (2016) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.02.006 · Cited by 45
Laboratory‐based surveillance of Candida auris in Colombia, 2016–2020
Escandón, P., Cáceres, D. H., Lizarazo, D., Lockhart, S. R., Lyman, M., & Duarte, C. (2021) · Mycoses · doi:10.1111/myc.13390 · Cited by 38
Advances in Understanding Human Genetic Variations That Influence Innate Immunity to Fungi
Merkhofer, R. M., & Klein, B. S. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00069 · Cited by 36 · cited 2×
“defects in specific adaptive immunity and human ancestry have been identified [50,51].”
BackgroundTam, J. M., Reedy, J. L., Lukason, D. P., Kuna, S. G., Acharya, M., Khan, N. S., Negoro, P. E., Xu, S., Ward, R., Feldman, M. B., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801384 · Cited by 35 · cited 2×
“Other CARD9 polymorphisms have recently been reported [46].”
BackgroundRodrigues, D. K. D. B., Bonfietti, L. X., Garcia, R. A., Araújo, M. R., Rodrigues, J. S., Gimenes, V. M. F., & Melhem, M. D. S. C. (2021) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2020e10928 · Cited by 34 · cited 1×
“haemulonii, a multidrug-resistant species, was identified [100].”
García‐Effrón, G., Canton, E., Pemán, J., Dilger, A., Romá, E., & Perlin, D. S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00508-11 · Cited by 34 · cited 2×
“Changes in this balance determine overgrowth of the fungus [57] on surfaces where it is normally found, in addition to severe systemic infections with the involvement of several organs.”
BackgroundCáceres, D. H., Rivera, S. M., Armstrong, P. A., Escandón, P., Chow, N. A., Ovalle, M. V., Díaz, J., Derado, G., Salcedo, S., Berrío, I., et al. (2020) · Mycopathologia · doi:10.1007/s11046-020-00478-1 · Cited by 32
Investigational Agents for the Treatment of Resistant Yeasts and Molds
Seiler, G. T., & Ostrosky-Zeichner, L. (2021) · Current Fungal Infection Reports · doi:10.1007/s12281-021-00419-5 · Cited by 32 · cited 1×
“In addition, it is effective against resistant species of Candida [102].”
BackgroundGuo, J., Zhang, M., Qiao, D., Shen, H., Wang, L., Wang, D., Li, L., Liu, Y., Lu, H., Wang, C., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.644000 · Cited by 31 · cited 4×
“In recent years, many investigations have focused on the virulence profile of these strains, host–pathogen interactions and antifungal susceptibility of cryptic species; however, even so, studies in South America remain scarce [8,13,22].”
BackgroundInfluentialTiraboschi, I. N., Pozzi, N. C., Farías, L., García, S., & Fernández, N. (2017) · Revista chilena de infectología · doi:10.4067/s0716-10182017000500431 · Cited by 31 · cited 1×
“[14] analyzed 374 episodes of candidemia, reporting a prevalence of C.”
BackgroundAn integrative genomics approach identifies novel pathways that influence candidaemia susceptibility
Matzaraki, V., Gresnigt, M. S., Jaeger, M., Ricaño-Ponce, I., Johnson, M. D., Oosting, M., Franke, L., Withoff, S., Perfect, J. R., Joosten, L. A. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180824 · Cited by 29 · cited 5×
“Due to recent advances in personalized medicine through genome-wide association studies (GWAS) [52], it would be crucial to study the genomic ancestry composed of all the different human races that inhabit our region.”
BackgroundInfluentialCOVID-19 and invasive fungal coinfections: A case series at a Brazilian referral hospital
Martins, A. C., Psaltikidis, E. M., de Lima, T. C., Fagnani, R., Schreiber, A. Z., Conterno, L. D. O., Kamei, K., Watanabe, A., Trabasso, P., Resende, M. R., et al. (2021) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2021.101175 · Cited by 28 · cited 2×
“[41] reported a frequency of 4/716, being C.”
BackgroundVigezzi, C., Icely, P. A., Dudiuk, C., Rodríguez, E., Miró, M. S., Castillo, G. D. V., Azcurra, A. I., Abiega, C., Caeiro, J. P., Riera, F. O., et al. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.100907 · Cited by 26 · cited 3×
“orthopsilosis, in addition to different antifungal susceptibility when comparing cryptic species of the central region of Argentina (2015–2016) [13].”
BackgroundSelf-citationContribution of TLR2 pathway in the pathogenesis of vulvovaginal candidiasis
Miró, M. S., Rodríguez, E., Vigezzi, C., Icely, P. A., García, L., Peinetti, N., Maldonado, C. A., Riera, F. O., Caeiro, J. P., & Sotomayor, C. E. (2017) · Pathogens and Disease · doi:10.1093/femspd/ftx096 · Cited by 25
Self-citationBerrío, I., Maldonado, N. A., de BEDOUT, C., Arango, K., Cano, L. E., Valencia, Y., Jiménez‐Ortigosa, C., Perlin, D. S., Gómez, B. L., Robledo, C. G., et al. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2017.11.010 · Cited by 23
Candidiasis of the Central Nervous System in Neonates and Children With Primary Immunodeficiencies
Drummond, R. A., & Lionakis, M. S. (2018) · Current Fungal Infection Reports · doi:10.1007/s12281-018-0316-y · Cited by 23 · cited 1×
“[73] observed that in patients with CARD9 deficiency, the defective recruitment of neutrophils to the brain contributed to an increased fungal burden in the central nervous system (CNS).”
BackgroundAguilar, G., Araujo, P., Lird, G., Insaurralde, S., Kawabata, A., Ayala, E., Irala, J. D., & Argüello, R. (2020) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2020.34 · Cited by 13
Moreno, X., Reviakina, V. A., Panizo, M. M., Ferrara, G. A., García, N., Alarcón, V., Garcés, M. F., & Dolande, M. (2017) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2016.11.005 · Cited by 12
Qin, J., Yang, H., Shan, Z., Jiang, L., & Zhang, Q. (2021) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001434 · Cited by 12
Gil-Alonso, S., Quindós, G., Cantón, E., Eraso, E., & Jauregizar, N. (2019) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2018.12.001 · Cited by 11 · cited 1×
“In recent years, many investigations have focused on the virulence profile of these strains, host–pathogen interactions and antifungal susceptibility of cryptic species; however, even so, studies in South America remain scarce [8,13,22].”
BackgroundCandidiasis invasora: un enfoque a la infección en el sistema nervioso central
Vigezzi, C., Riera, F. O., Rodríguez, E., Icely, P. A., Miró, M. S., Figueredo, C. M., Caeiro, J. P., & Sotomayor, C. E. (2020) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2020.06.003 · Cited by 10 · cited 3×
“sion may develop cerebral micro abscesses, which constitute a serious complication [69].”
BackgroundInfluentialSelf-citationContribution of TLR2 pathway in the pathogenesis of vulvovaginal candidiasis
Miró, M. S., Rodríguez, E., Vigezzi, C., Icely, P. A., García, L., Peinetti, N., Maldonado, C. A., Riera, F. O., Caeiro, J. P., & Sotomayor, C. E. (2018) · Pathogens and Disease · doi:10.1093/femspd/fty050 · Cited by 6
Self-citationCaeiro, J. P., & Riera, F. O. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0171-9 · Cited by 3 · cited 1×
“It may present as severe sepsis, septic shock, and multiple-organ failure, similar to bacterial infection [93].”
BackgroundSelf-citationIcely, P. A., Vigezzi, C., Rodríguez, E., Miró, M. S., Salido Renteria, B., & Sotomayor, C. E. (2021) · Journal of Bacteriology and Mycology · doi:10.26420/jbacteriolmycol.2021.1168 · Cited by 2
Self-citation
Cited by
El-Saadony, M. T., Saad, A. M., Mohammed, D. M., Korma, S. A., Alshahrani, M. Y., Ahmed, A. E., Ibrahim, E. H., Salem, H. M., Alkafaas, S. S., Saif, A. M., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1491777 · Cited by 197
“Nosocomial infections may result from invasive candidiasis, or candidemia, which is the most prevalent opportunistic mycosis worldwide (151).”
Epidemiology of Invasive Candidiasis
Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology · doi:10.2147/clep.s459600 · Cited by 109
Saied, M., 亮, 前., Abdelghany, T. M., Amin, B. H., & 陽祐, 中. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124709 · Cited by 50
The Role of Novel Antifungals in the Management of Candidiasis: A Clinical Perspective
Ordaya, E. E., Clement, J., & Vergidis, P. I. (2023) · Mycopathologia · doi:10.1007/s11046-023-00759-5 · Cited by 45
“Compared to C. albicans isolates which commonly remain susceptible to fluconazole, non-albicans species demonstrate variable susceptibility to antifungal agents [7–9].”
BackgroundInfluentialYassin, M. T., Al-Otibi, F. O., Al-Askar, A. A., & Elmaghrabi, M. M. (2023) · Microorganisms · doi:10.3390/microorganisms11081957 · Cited by 37
“Candidemia continues to be a significant contributor to morbidity and mortality within healthcare environments [10].”
Background
Metadata
- Authors
- Riera, F. O., Caeiro, J. P., Angiolini, S. C., Vigezzi, C., Rodriguez, E., Icely, P. A., & Sotomayor, C. E.
- Affiliations
- Fundacion Allende (AR)
- Hospital Privado (AR)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Research Group of Immunology and Mycology, Córdoba 5000, Argentina
- Corresponding author
- Sotomayor, Claudia Elena
- ORCID
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2022-06-30
- Volume
- 11
- Issue
- 7
- Pages
- 877
- ISSN
- 2079-6382 (ISSN-L)
- PMC
- PMC9312041
- OpenAlex
- W4283760440
- Cited by
- 65
- References
- 103
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 16 · 2023: 19 · 2022: 6
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Antibiotics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Agencia Nacional de Promoción Científica y Tecnológica-FONCyT (PICT-2015-1393, 30720150100934CB, 33720180100058CB, PIP-112 201501-00652CO)
- SECyT-UNC (PICT-2015-1393, 30720150100934CB, 33720180100058CB, PIP-112 201501-00652CO)
- CONICET (PICT-2015-1393, 30720150100934CB, 33720180100058CB, PIP-112 201501-00652CO)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- invasive candidiasis, candidemia, Candida species distribution, non-albicans Candida, Candida parapsilosis, Candida tropicalis, Candida glabrata, Candida auris, antifungal resistance, host susceptibility, fungal pathogenesis, immune response, candidemia mortality, South America
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.